Ophthalmologic compromise following SARS-CoV-2 vaccinations

Ophthalmologic compromise following SARS-CoV-2 vaccinations

Bibliographic Details
Main Author:	Josef Finsterer
Format:	Article
Language:	English
Published:	SpringerOpen 2022-11-01
Series:	Journal of Ophthalmic Inflammation and Infection
Subjects:	SARS-CoV-2 Vaccination Ophthalmology Vision COVID-19
Online Access:	https://doi.org/10.1186/s12348-022-00318-x

Similar Items

Hypophysitis or pituitary apoplexy following a SARS-CoV-2 vaccination
by: Josef Finsterer
Published: (2023-09-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

Letter to the Editor: Anti-SARS-CoV-2 Vaccination-Related Polyradiculitis Requires Early Diagnosis and Treatment to Improve the Outcome
by: Josef Finsterer
Published: (2023-07-01)

Eosinophilic fasciitis following SARS-CoV-2 vaccination
by: Victoria Lobo Antuña, MD, et al.
Published: (2023-06-01)

An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
by: Josef Finsterer
Published: (2024-10-01)

Spot the adenoma after pituitary apoplexy following a SARS-CoV-2 vaccination
by: Josef Finsterer, et al.
Published: (2023-09-01)

Neurological side effects of SARS-CoV-2 vaccination are common and can be severe
by: Josef Finsterer
Published: (2025-02-01)

Myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related
by: J. Finsterer, et al.
Published: (2023-09-01)

SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala
by: Pamela Davila-Siliezar, et al.
Published: (2021-01-01)

The frequency of SARS-CoV-2 infection/vaccination-related chorea depends on the inclusion/exclusion criteria
by: Josef Finsterer, et al.
Published: (2023-12-01)

Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach
by: Taimoor Khan, et al.
Published: (2022-04-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Association of SARS-CoV-2 Vaccinations with SARS-CoV-2 Infections, ICU Admissions and Deaths in Greece
by: Foteini Malli, et al.
Published: (2022-02-01)

Vaccination caused an underestimation of the cumulative incidence of SARS-CoV-2 infection
by: Nana Owusu-Boaitey
Published: (2025-02-01)

Comparison of Four Systems for SARS-CoV-2 Antibody at Three Time Points after SARS-CoV-2 Vaccination
by: Jong Do Seo, et al.
Published: (2022-05-01)

Waning immunity to SARS-CoV-2 following vaccination or infection
by: Carlos Hernandez-Suarez, et al.
Published: (2022-10-01)

The Antibodies’ Response to SARS-CoV-2 Vaccination: 1-Year Follow Up
by: Eleonora Nicolai, et al.
Published: (2023-09-01)

Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
by: Abdul Aziz Al-Fattah Yahaya, et al.
Published: (2023-02-01)

SARS-CoV-2 Vaccine Effectiveness in Hospitalized Patients: A Multicenter Test-Negative Case–Control Study
by: Ireri Thirión-Romero, et al.
Published: (2023-11-01)

Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination
by: A. Riccomi, et al.
Published: (2024-04-01)

Ex Vivo Immune Responsiveness to SARS-CoV-2 Omicron BA.5.1 Following Vaccination with Unmodified mRNA-Vaccine
by: Anna Sabrina Kuechler, et al.
Published: (2023-03-01)

The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines
by: Zhongjie Sun, et al.
Published: (2022-07-01)

Development of SARS-CoV-2 Vaccine: Challenges and Prospects
by: Tooba Mahboob, et al.
Published: (2023-04-01)

SARS-CoV-2 in dialysis patients and the impact of vaccination
by: Louise Rachel Moore, et al.
Published: (2022-09-01)

Multi-Subunit SARS-CoV-2 Vaccine Design Using Evolutionarily Conserved T- and B- Cell Epitopes
by: Burkitkan Akbay, et al.
Published: (2021-06-01)

SARS‐CoV‐2‐related polyradiculitis must be preceded by PCR‐confirmed COVID‐19
by: Josef Finsterer
Published: (2023-04-01)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
by: Ashutosh Khaswal, et al.
Published: (2022-07-01)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
by: Francesco Sessa, et al.
Published: (2021-03-01)

Neuroretinitis after the second injection of a SARS-CoV-2-vaccine: A case report
by: Chaeyeon Lee, et al.
Published: (2022-09-01)

An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
by: Varghese Edwin Hillary, et al.
Published: (2023-03-01)

Effect of Vaccination against SARS-CoV-2 on Long COVID-19: A Narrative Review
by: Andreas G. Tofarides, et al.
Published: (2022-12-01)

Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population
by: Birgit Weinberger
Published: (2021-12-01)

On the SARS-CoV-2 Variants
by: Fabio Scarpa, et al.
Published: (2024-03-01)

Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval
by: Ebenezer Tumban
Published: (2020-12-01)

Development of DNA Vaccine Candidate against SARS-CoV-2
by: Xingyun Wang, et al.
Published: (2022-05-01)

Progress and Prospects on Vaccine Development against SARS-CoV-2
by: Jinyong Zhang, et al.
Published: (2020-03-01)

SARS-CoV-2-related cardiovascular complications in the tropics
by: Josef Finsterer, et al.
Published: (2022-12-01)

Re-infections with SARS-CoV-2 require a clarification of favourable risk factors
by: Josef Finsterer
Published: (2023-11-01)

Development of an Inactivated Vaccine against SARS CoV-2
by: Shaikh Terkis Islam Pavel, et al.
Published: (2021-11-01)

Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model
by: Devanshi R. Patel, et al.
Published: (2024-03-01)